SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-068092
Filing Date
2024-06-04
Accepted
2024-06-04 11:00:19
Documents
13
Period of Report
2024-05-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2416319d1_8k.htm   iXBRL 8-K 23589
  Complete submission text file 0001104659-24-068092.txt   194496

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acur-20240531.xsd EX-101.SCH 3021
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20240531_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20240531_pre.xml EX-101.PRE 22363
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2416319d1_8k_htm.xml XML 3576
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10113 | Film No.: 241016472
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)